Active ingredientFevipiprantCat. No. P-F038-001CAS 872365-14-5Family · Pharmaceutical analytical standards
Fevipiprant
An oral antagonist of the DP2 (CRTH2) receptor for prostaglandin D2, studied for asthma: it reached phase III by 2016, but the trials did not show a significant improvement and development was stopped in 2019. This family brings together the active ingredient, metabolites and labelled standards.
Did you know?Its target is also known as CRTH2, short for 'chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells': the same receptor is also found on eosinophils and basophils.
Go to the active ingredient →Active ingredientFevipiprantCat. No. P-F038-001CAS 872365-14-5
MetaboliteFevipiprant Acyl GlucuronideCat. No. P-F038-002
Isotopically labelledFevipiprant Acyl Glucuronide-d5Cat. No. P-F038-003
Isotopically labelledFevipiprant-d5Cat. No. P-F038-004No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.